Competitive Performance of Carbon “Quantum” Dots in Optical Bioimaging by Cao, Li et al.
Theranostics 2012, 2(3) 
 
 
http://www.thno.org 
295 
T Th he er ra an no os st ti ic cs s   
2012; 2(3):295-301. doi: 10.7150/thno.3912 
Research Paper 
Competitive Performance of Carbon “Quantum” Dots in Optical Bioimaging 
Li Cao, Sheng-Tao Yang, Xin Wang, Pengju G. Luo, Jia-Hui Liu, Sushant Sahu, Yamin Liu, Ya-Ping Sun  
Department of Chemistry and Laboratory for Emerging Materials and Technology, Clemson University, Clemson, South 
Carolina 29634-0973, USA.  
 Corresponding author: Tel: 864-656-5026, Fax: 864-656-6613, E-mail: syaping@clemson.edu 
© Ivyspring International Publisher. This is an open-access article distributed under the terms of the Creative Commons License (http://creativecommons.org/ 
licenses/by-nc-nd/3.0/). Reproduction is permitted for personal, noncommercial use, provided that the article is in whole, unmodified, and properly cited. 
Received: 2011.12.04; Accepted: 2012.01.01; Published: 2012.03.07 
Abstract 
Carbon-based  “quantum”  dots  or  carbon  dots  are  surface-functionalized  small  carbon 
nanoparticles.  For  bright  fluorescence  emissions,  the  carbon  nanoparticles  may  be  sur-
face-doped with an inorganic salt and then the same organic functionalization. In this study, 
carbon dots without and with the ZnS doping were prepared, followed by gel-column frac-
tionation to harvest dots of 40% and 60% in fluorescence quantum yields, respectively. These 
highly fluorescent carbon dots were evaluated for optical imaging in mice, from which bright 
fluorescence images were obtained. Of particular interest was the observed competitive 
performance of the carbon dots in vivo to that of the well-established CdSe/ZnS QDs. The 
results  suggest  that  carbon  dots  may  be  further  developed  into  a  new  class  of 
high-performance yet nontoxic contrast agents for optical bioimaging. 
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1. Introduction 
Small carbon nanoparticles have been shown as 
versatile precursors for brightly fluorescent nano-dots 
[1-15], with the observed optical properties in solution 
phenomenologically similar to and performance-wise 
comparable with those of the well-established semi-
conductor quantum dots (QDs) [9, 16-19]. Structurally, 
the fluorescent carbon-based “quantum” dots (or of-
ten referred to as carbon dots) are small carbon na-
noparticles  with  relatively  simple  particle  surface 
functionalization  [1,2,7,10,11]. Carbon  dots  with  oli-
gomeric  polyethylene  glycol  diamine  (PEG1500N, 
Scheme 1/Figure S1) [20] as the surface functionaliza-
tion agent were shown to be nontoxic [21], amenable 
to fluorescence bioimaging applications in vitro and in 
vivo  [10,11,22,23].  More  recently,  highly  fluorescent 
carbon dots with emission quantum yields more than 
50% were obtained by surface-doping the core carbon 
nanoparticles  with  an  inorganic  salt  such  as  ZnS 
(Scheme 1/Figure S1) or TiO2 [20,24], and/or by ap-
plying  a  gel-column  fractionation  scheme  to  the 
as-synthesized  carbon  dots  samples  [9,20].  The 
brighter dots thus harvested promise more and better 
opportunities for fluorescence bioimaging, especially 
for uses in vivo to improve the contrast against tissue 
background. Here we report an experimental valida-
tion on the use of these highly fluorescent carbon dots 
for imaging in mice, with especially a demonstration 
on the competitive performance of these dots to that 
of  the  well-established  semiconductor  QDs  under 
purposely matching experimental conditions. 
2. Experimental Section 
2.1. Materials 
Carbon nano-powders, O,O’-bis(3-aminopropyl) 
polyethylene glycol (MW ~ 1,500, PEG1500N) and thio-
nyl  chloride  (>99%)  were  purchased  from  Aldrich, 
zinc  acetate  dihydrate  (Zn(OOCCH3)2•2H2O,  >98%) 
and  sodium  sulfide  (Na2S•9H2O,  >98%)  from  Alfa, 
Ivyspring  
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and nitric acid, N,N-dimethylformamide (DMF, 99%), 
and sodium dodecyl sulfate (SDS, 99%) from VWR. 
The  aqueous  CdSe/ZnS  quantum  dots  solution 
(Qdot® 525 ITK™ amino (PEG) QDs) was acquired 
from  Invitrogen.  Millipore  Durapore  membrane  fil-
ters (pore size 0.22 μm) and dialysis membrane tubing 
were supplied by Spectrum Laboratories. Water was 
deionized  and  purified  by  being  passed  through  a 
Labconco WaterPros water purification system. 
 
 
 
Figure S1.  (Scheme 1) Cartoon illustrations of non-doped (left) 
and doped (right) carbon dots [20]. 
 
2.2. Measurement 
Baxter  Megafuge  (model  2630)  and  Beck-
man-Coulter  ultracentrifuge  (Optima  L90K  with  a 
type 90 Ti fixed-angle rotor) were used. UV/vis ab-
sorption  spectra  were  recorded  on  a  Shimadzu 
UV2101-PC spectrophotometer. Fluorescence spectra 
were measured on a Jobin-Yvon emission spectrome-
ter equipped with a 450 W xenon source, Gemini-180 
excitation  and  Tirax-550  emission  monochromators, 
and a photon counting detector (Hamamatsu R928P 
PMT  at  950  V).  Quinine  sulfate  and 
9,10-bis(phenylethynyl)-anthracene  were  used  as 
standards in the determination of fluorescence quan-
tum yields by the relative method (matching the ab-
sorbance  at  the  excitation  wavelength  between  the 
sample and standard solutions and comparing their 
corresponding  integrated  total  fluorescence  intensi-
ties).  Atomic  force  microscopy  (AFM)  images  were 
acquired  in  the  acoustic  AC  mode  on  a  Molecular 
Imaging PicoPlus AFM system equipped with a mul-
tipurpose  scanner  and  a  NanoWorld  point  probe 
NCH  sensor.  Transmission  electron  microscopy 
(TEM)  characterization  was  carried  out  on  Hitachi 
9500  TEM  and  Hitachi  HD-2000  S-TEM  systems. 
Confocal  fluorescence  images  were  obtained  on  a 
Leica laser scanning confocal fluorescence microscope 
(DM IRE2, with Leica TCS SP2 SE scanning system) 
equipped with an argon ion laser (JDS Uniphase). The 
fluorescence  imaging  in  mice  was  performed  on  a 
MAG  Biosystems  Lumazone  FA  in  vivo  Imaging 
System equipped with an Asahi Max-301 xenon arc 
source for excitation through a liquid light guide and 
a  Princeton  Instruments  PIXIS:1024B  digital  CCD 
camera system as detector. Band-pass and cut-off fil-
ters  were  used  for  the  selection  of  excitation  and 
emission wavelengths.  
2.3. Carbon Dots  
A  carbon  nano-powder  sample  (2  g)  was  re-
fluxed in an aqueous nitric acid solution (2.6 M, 200 
mL) for 12 h. The mixture back at room temperature 
was dialyzed against fresh water, followed by centri-
fuging at 1,000g to retain the supernatant. The  sur-
face-oxidized  small  carbon  nanoparticles  recovered 
from the supernatant (100 mg) were refluxed in neat 
thionyl chloride for 6 h. Upon the removal of excess 
thionyl chloride on a rotary evaporator with a vacu-
um pump, the sample was mixed well with PEG1500N 
(1 g) in a flask. The mixture was heated to 110 °C, and 
vigorously stirred at that temperature under nitrogen 
protection for 3 days. The sample back at room tem-
perature was dispersed in water, followed by centri-
fuging  at  25,000g  to  retain  the  supernatant  as  an 
aqueous solution of the as-prepared carbon dots. The 
sample  solution  was  concentrated  and  then  loaded 
onto a Sephadex G-100TM gel-column packed in house 
for fractionation [9]. Fluorescence quantum yields of 
the fractions were determined, and those more fluo-
rescent were combined into a single aqueous solution 
of carbon dots (40% in fluorescence quantum yield) 
for further characterization and bioimaging. 
For  the  surface-doping  with  ZnS,  the  sur-
face-oxidized  carbon  nanoparticles  (600  mg)  were 
dispersed in DMF (200 mL) via sonication for 30 min, 
and  to  the  suspension  was  first  added 
Zn(OOCCH3)2•2H2O (680 mg, 3.1 mmol) under vig-
orous stirring and then slow dropwise addition of an 
aqueous Na2S solution (0.62 M, 5 mL) at room tem-
perature. The mixture was centrifuged at 3,000g, and 
the precipitate was retained and repeatedly washed 
with distilled water to obtain the ZnS-doped carbon 
nanoparticles (881 mg). 
The  ZnS-doped  carbon  nanoparticles  (200  mg) 
were dispersed in an aqueous SDS solution (1 wt%, 
120 mL) via sonication for 30 min. Upon filtration, the 
filter  cake  was  washed  repeatedly  with  water  and 
then dried. The solid sample was mixed thoroughly 
with PEG1500N (1.9 g), and the mixture was heated to 
110 °C and stirred at that temperature for 72 h under 
nitrogen  protection.  The  reaction  mixture  back  at Theranostics 2012, 2(3) 
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room temperature was dispersed in water, followed 
by centrifuging at 25,000g to retain the supernatant as 
an  aqueous  solution  of  as-prepared  CZnS-Dots.  The 
sample solution was similarly concentrated and then 
fractionated  on  the  same  Sephadex  G-100TM 
gel-column [20]. Fluorescence quantum yields of the 
fractions  were  determined,  and  those  more  fluores-
cent were combined into a single aqueous solution of 
CZnS-Dots  (60%  in  fluorescence  quantum  yield)  for 
further characterization and bioimaging. 
2.4. Imaging in Mice  
All of the animal experiments were performed at 
Clemson University by strictly following the IACUC 
(Institutional Animal Care and Use Committee) ap-
proved  protocols.  Female  DBA/1  mice  (~25  g,  ac-
quired  from  Harlan)  were  housed  in  plastic  cages 
(three mice/cage) at the Godley-Snell Research Center 
at Clemson University and kept on a 12 h light/dark 
cycle, with food and water provided ad libitum. Fol-
lowing the acclimation of  one week, the mice were 
randomly divided into groups of 3 mice per group for 
imaging  evaluations.  Throughout  the  imaging  ex-
periments the mice were kept under anaesthesia (3% 
isoflurane flow). Two injection modes (subcutaneous 
and front extremity) were used for the in vivo imaging. 
Before  subcutaneous  injection,  the  back  area  sur-
rounding the injection point on the mouse was shaved 
to  minimize  autofluorescence.  The  control  group  in 
both  injection  modes  was  injected  with  equivalent 
volume of phosphate buffered saline (PBS). For the 
front extremity injection, the mice 24 h post-injection 
were sacrificed by CO2 treatment under anaesthesia. 
The axillary lymph nodes were dissected for fluores-
cence imaging. All images were processed and ana-
lyzed by using the NIH-commissioned and supplied 
ImageJ  software  (http://rsbweb.nih. 
gov/ij/). 
3. Results and Discussion 
Small carbon nanoparticles (mostly less than 10 
nm  in  diameter)  were  harvested  from  the  commer-
cially  supplied  carbon  nano-powders  (Aldrich)  by 
first  the  aqueous  nitric  acid  treatment  and  then  a 
combination  of  dialysis  to  remove  impurities  and 
vigorous centrifuging to retain the supernatant. These 
nanoparticles  were  functionalized  with  PEG1500N  in 
classical amidation reaction to  yield PEGylated car-
bon  dots  (Scheme  1/Figure  S1).  The  as-prepared 
sample was fractionated on a gel-column (SephadexTM 
G-100) to harvest the more fluorescent portion of the 
sample  [9],  with  the  corresponding  fluorescence 
quantum yield in the green of 40% (440 nm excitation, 
figure 1). 
The sample solution was diluted for the prepa-
ration  of  specimens  for  characterization  by  micros-
copy techniques. Both AFM and TEM results showed 
dot-like images (figure 2), agreeing well with those for 
carbon dots reported previously [9]. 
 
 
 
 
 
 
 
 
Figure  1. Absorption (ABS) and fluorescence (FLSC, 440 nm 
excitation) spectra of the carbon dots without (upper) and with 
the ZnS doping (lower) in aqueous solutions, with fluorescence 
quantum yields of 40% and 60%, respectively. In the insets are 
photos of the corresponding solutions (excitation at 440 nm and 
emissions monitored through a 530 nm cut-off filter). Theranostics 2012, 2(3) 
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Figure 2. TEM (left) and AFM (right) images of the carbon dots 
(without ZnS doping) used in the optical imaging experiments. 
 
 
The carbon nanoparticles could be suspended in 
aqueous solution in a relatively stable fashion, thus 
serving as nucleation centers in the titration of zinc 
acetate with sodium sulfide for the formation of ZnS 
to  yield  ZnS-doped  carbon  nanoparticles  [24].  The 
surface-doping  level  likely  varied  from  particle  to 
particle, so that a surfactant (sodium dodecyl sulfate 
or SDS)-assisted dispersion procedure in favor of the 
carbon nanoparticles with more ZnS doping was used 
to exclude those with no or a negligible level of dop-
ing. Subsequently, those nanoparticles with the sur-
face completely covered by ZnS (thus  no accessible 
carboxylic  acid  moieties  on  the  particle  surface  for 
reactions with amino molecules) were discriminated 
in the functionalization chemistry with PEG1500N [20]. 
The functionalization reaction conditions were similar 
to  those  used  for  carbon  dots  without  the  surface 
doping, resulting in ZnS-doped carbon dots (denoted 
as CZnS-Dots). According to thermogravimetric analy-
sis (TGA), the estimated core composition in terms of 
C:ZnS  molar  ratio  in  the  CZnS-Dots  was  about  20:1. 
The as-prepared sample was similarly fractionated on 
the gel-column to harvest more fluorescent CZnS-Dots 
[20], with the observed fluorescence quantum yield in 
the green of 60% (440 nm excitation, figure 1). These 
dots were diluted for the preparation of specimens for 
characterization  by  AFM  and  TEM,  and  the  repre-
sentative results are shown in figure 3. The vigorously 
diluted solution was also used to disperse the dots on 
cover-glass surface for confocal fluorescence imaging 
under  the  same  specimen  and  measurement  condi-
tions as those for commercially supplied CdSe/ZnS 
QDs (Invitrogen Qdot 525 ITKTM amino (PEG) QDs, 
fluorescence quantum yield ~60% verified). As shown 
in  figure  4,  the  well-dispersed  CZnS-Dots  and  the 
CdSe/ZnS  QDs  are  quite  similar  in  fluorescence 
brightness at essentially the individual dot level. 
 
 
Figure 3. Representative TEM (left) and AFM (right) images of the 
ZnS-doped carbon dots (CZnS-Dots) used in the optical imaging 
experiments. 
 
 
Figure 4. Confocal fluorescence images (458 nm excitation, 10 μm for the scale bars) of the CZnS-Dots (left) and the commercially 
supplied CdSe/ZnS QDs (right). In the inset is a comparison on the average image intensity (IAV) for 60 dots between the two specimens. Theranostics 2012, 2(3) 
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The highly fluorescent carbon dots without and 
with the ZnS doping (quantum yields 40% and 60%, 
respectively) were evaluated in terms of fluorescence 
imaging in mice [23]. The animal experiments were 
performed by strictly following the IACUC (Institu-
tional  Animal  Care  and  Use  Committee)  approved 
protocols. Female DBA/1 mice (~25 g) were housed in 
plastic  cages  (three  mice/cage)  at  the  Godley-Snell 
Research Center for animal research at Clemson Uni-
versity on a 12 h light/dark cycle and provided with 
food and water ad libitum. Following the acclimation 
of one  week, the mice were randomly divided into 
groups of three mice per group. For the injection and 
subsequent imaging, the mice were kept under anes-
thesia with 3% isoflurane flow. 
Before the subcutaneous injection, the back area 
surrounding  the  injection  point  on  the  mouse  was 
shaved to avoid autofluorescence. The injection vol-
ume was kept at 20 µL, with the solution concentra-
tion adjusted to match the targeted optical density at 
the excitation wavelength. As shown in figure 5, flu-
orescence emissions from the subcutaneously injected 
dots could readily be detected in a Lumazone FA in 
vivo imaging system (MAG Biosystems), with a rela-
tively  shorter  fluorescence  collection  time  and  im-
proved imaging contrast in comparison with those in 
the  use  of  as-prepared  less  fluorescent  carbon  dots 
[23]. The image brightness was obviously higher for 
the  CZnS-Dots  sample,  consistent  with  the  corre-
sponding higher fluorescence quantum yield in solu-
tion. In mice the subcutaneously injected carbon dots 
diffused relatively slowly, with the gradual fading of 
fluorescence signals in about 24 h post-injection. 
 
 
Figure 5. Top: Subcutaneously injected carbon dots (upper spot) and CZnS-Dots (lower spot) of similar optical densities in mice (470 nm 
and 525 nm band-pass filters for excitation and emission, respectively). Bottom: Subcutaneously injected CZnS-Dots (upper spot) and 
Invitrogen Qdot 525 ITKTM amino (PEG) QDs (lower spot) of similar optical densities in mice (434 nm band-pass filter for excitation and 
474 nm cut-off filter for emission collection). The color-coded images (right) were processed with ImageJ from NIH. 
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In  a  comparison  of  fluorescence  imaging  per-
formance  with  commercially  supplied  CdSe/ZnS 
QDs (Invitrogen Qdot 525 ITKTM amino (PEG) QDs), 
the concentration of the subcutaneously injected QDs 
was  adjusted  such  that  the  optical  density  was  ap-
proximately  the  same  as  that  of  the  carbon  dots  in 
vivo. The resulting fluorescence images for CZnS-Dots 
and  the  CdSe/ZnS  QDs  in  mice  were  of  similar 
brightness  (figure  5),  consistent  with  their  similar 
fluorescence quantum yields in solution and compa-
rable  fluorescence  imaging  results  at  the  individual 
dot level (figure 4). 
For potential uses of carbon dots for fluorescence 
imaging in vivo, a relatively straightforward demon-
stration  is  on  tracking  the  migration  of  the  dots 
through  lymph  vessels  in  mice  following  the  paw 
injection [23,25,26]. For the highly fluorescent carbon 
dots without and with ZnS doping (quantum yields 
40% and 60%, respectively), they could both migrate 
along the arm upon their  intradermal injection into 
the front extremity (figure 6). However, the migration 
of  the  CZnS-Dots  was  apparently  less  pronounced, 
with the relative brightness in the fluorescence images 
(figure  6)  of  the  migrated  dots  suggesting  less 
CZnS-Dots  (more  fluorescent)  migrated.  The  axillary 
lymph  nodes  were  harvested  and  dissected  at  24  h 
post-injection,  where  strong  fluorescence  emissions 
from the carbon dots were observed (figure 6), further 
confirming the migration of the dots and the preser-
vation of their fluorescence properties in vivo. 
The  improved  optical  imaging  performance  of 
these  more  fluorescent  carbon  dots  in  mice  further 
confirms that the excellent fluorescence properties of 
carbon dots observed in solutions and on surface at 
the  individual  dot  level  are  preserved  in vivo,  sug-
gesting  significant  application  potentials  of  carbon 
dots. Particularly encouraging is the fact that the in 
vivo performance of the carbon dots is competitive to 
that of the well-established CdSe/ZnS QDs, beyond 
the obvious advantage of carbon dots being nontoxic 
according  to  available  experimental  evaluations 
[10,11,21,27-29]. The results from this study justify the 
further development of carbon dots into a new class of 
high-performance yet benign contrast agents for op-
tical bioimaging. 
 
 
Figure 6. Intradermally injected carbon dots (upper) and CZnS-Dots (lower) of similar optical densities in mice, with images of dissected 
lymph nodes in the insets (470 nm and 525 nm band-pass filters for excitation and emission, respectively). The color-coded images (right) 
were processed with ImageJ from NIH. Theranostics 2012, 2(3) 
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